006280.KS
006280.KS
KR7006280002
GC Biopharma Corp.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 1.991.279.093.820 1.679.891.941.470
18.5%
Cost of Revenue 1.437.159.054.890 1.197.959.660.980
20.0%
Gross Profit 554.120.038.930 481.932.280.490
15.0%
484.970.182.000 449.824.933.000
7.8%
Operating Income 69.149.856.930 32.107.347.490
115.4%
Pretax Income -35.331.026.420 -41.109.728.850
14.1%
Net Income Common Stockholders -4.673.833.010 -26.280.215.150
82.2%
-- --
--
-- --
--
ende